Precigen, Inc. (PGEN)
4.52
-0.14
(-3.00%)
USD |
NASDAQ |
Nov 13, 16:00
4.52
0.00 (0.00%)
After-Hours: 19:59
Precigen Profit Margin (Quarterly) : 48.24% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 48.24% |
| June 30, 2026 | 36.51% |
| March 31, 2026 | -34.10% |
| December 31, 2025 | -514.9% |
| September 30, 2025 | -5.01K% |
| June 30, 2025 | -3.11K% |
| March 31, 2025 | -4.04K% |
| December 31, 2024 | -1.66K% |
| September 30, 2024 | -2.52K% |
| June 30, 2024 | -8.20K% |
| March 31, 2024 | -2.23K% |
| December 31, 2023 | -2.69K% |
| September 30, 2023 | -1.44K% |
| June 30, 2023 | -1.15K% |
| March 31, 2023 | -1.23K% |
| December 31, 2022 | -1.26K% |
| September 30, 2022 | -45.71% |
| June 30, 2022 | -895.2% |
| March 31, 2022 | -433.5% |
| December 31, 2021 | -724.7% |
| September 30, 2021 | -789.6% |
| June 30, 2021 | -811.0% |
| March 31, 2021 | -89.12% |
| December 31, 2020 | -5.01% |
| September 30, 2020 | -116.8% |
| Date | Value |
|---|---|
| June 30, 2020 | -51.63% |
| March 31, 2020 | -69.86% |
| December 31, 2019 | -212.2% |
| September 30, 2019 | -268.1% |
| June 30, 2019 | -98.38% |
| March 31, 2019 | -234.2% |
| December 31, 2018 | -666.6% |
| September 30, 2018 | -181.0% |
| June 30, 2018 | -147.6% |
| March 31, 2018 | -98.61% |
| December 31, 2017 | -44.07% |
| September 30, 2017 | -88.74% |
| June 30, 2017 | -36.12% |
| March 31, 2017 | -60.24% |
| December 31, 2016 | -97.63% |
| September 30, 2016 | -61.27% |
| June 30, 2016 | -95.30% |
| March 31, 2016 | -150.4% |
| December 31, 2015 | -80.18% |
| September 30, 2015 | -73.13% |
| June 30, 2015 | -92.43% |
| March 31, 2015 | 76.23% |
| December 31, 2014 | 57.67% |
| September 30, 2014 | -254.1% |
| June 30, 2014 | -449.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.02% |
| Aldeyra Therapeutics, Inc. | -- |
| Repligen Corp. | -18.36% |
| AC Immune SA | -269.7% |
| Inovio Pharmaceuticals, Inc. | -16.46K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 58.00% |
| Return on Assets | 14.37% |
| Return on Invested Capital | 17.38% |
| Gross Profit Margin (Quarterly) | 90.79% |
| Operating Margin (Quarterly) | 52.13% |
| Return on Net Operating Assets | 27.10% |